Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

RebelBio

Founders Bill Liao Sean O'Sullivan

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 136
Average round size
info
The average size of a deal this fund participated in
$134K
Portfolio companies 75
Rounds per year 15.11
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.44
Key employees 1
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Sustainability
  • Pharmaceutical
Summary

RebelBio is the famous VC, which was founded in 2014. The main office of represented VC is situated in the London. The venture was found in Europe in United Kingdom.

The fund is generally included in 13-24 deals every year. The common things for fund are deals in the range of 100 thousands - 1 million dollars. The high activity for fund was in 2017. The typical startup value when the investment from RebelBio is 1-5 millions dollars.

Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Canada. Among the most popular portfolio startups of the fund, we may highlight Perfect Day, Chinova Bioworks, Pili. The fund has no exact preference in some founders of portfolio startups. When startup sums 1 of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Artificial Intelligence, Health Care.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the RebelBio, startups are often financed by SOSV, Enterprise Ireland, The Yield Lab. The meaningful sponsors for the fund in investment in the same round are Enterprise Ireland, The Yield Lab, Dorm Room Fund. In the next rounds fund is usually obtained by SOSV, Horizons Ventures, Enterprise Ireland.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of RebelBio:
Typical Co-investors
RebelBio is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after RebelBio:

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Because, Animals

Agriculture
Animal Feed
Consumer Goods
Food and Beverage
Pet
16 Apr 2021 Chicago, Illinois, United States

Pili

Biotechnology
Commercial
Industrial
Renewable Energy
$4M29 Mar 2021 Paris, Ile-de-France, France

AlgiKnit

Biotechnology
Manufacturing
Product Design
Sustainability
Textiles
$2M25 Mar 2021 New York, New York, United States

Chinova Bioworks

Biotechnology
Food and Beverage
08 Dec 2020 Fredericton, New Brunswick, Canada

Magellan Life Sciences

Biotechnology
Food and Beverage
Nutrition
02 Nov 2020 India, Andhra Pradesh, India

Pregenerate

Biotechnology
Life Science
Medical Device
06 Oct 2020 Vienna, Austria

Hexafly

Biotechnology
Organic
Sustainability
11 Jun 2020 Ireland, County Meath, Ireland

Machine Medicine Technologies

Artificial Intelligence
Computer Vision
Machine Learning
Software Engineering
$54825 May 2020 London, England, United Kingdom

VALANX Biotech

Biotechnology
Health Care
Medical
Pharmaceutical
28 Jan 2020 Graz, Styria, Austria

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent RebelBio?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 136
Average round size 134K
Rounds per year 15.11
Peak activity year 2017
Lead investments 0
Follow on index 0.44
Group Appearance index 0.99

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Because, Animals

Agriculture
Animal Feed
Consumer Goods
Food and Beverage
Pet
16 Apr 2021 Chicago, Illinois, United States

Pili

Biotechnology
Commercial
Industrial
Renewable Energy
$4M29 Mar 2021 Paris, Ile-de-France, France

AlgiKnit

Biotechnology
Manufacturing
Product Design
Sustainability
Textiles
$2M25 Mar 2021 New York, New York, United States

Chinova Bioworks

Biotechnology
Food and Beverage
08 Dec 2020 Fredericton, New Brunswick, Canada

Magellan Life Sciences

Biotechnology
Food and Beverage
Nutrition
02 Nov 2020 India, Andhra Pradesh, India

Pregenerate

Biotechnology
Life Science
Medical Device
06 Oct 2020 Vienna, Austria

Hexafly

Biotechnology
Organic
Sustainability
11 Jun 2020 Ireland, County Meath, Ireland

Machine Medicine Technologies

Artificial Intelligence
Computer Vision
Machine Learning
Software Engineering
$54825 May 2020 London, England, United Kingdom

VALANX Biotech

Biotechnology
Health Care
Medical
Pharmaceutical
28 Jan 2020 Graz, Styria, Austria
Crunchbase icon

Content report

The following text will be sent to our editors: